Archives: Agenda
PANEL DISCUSSION: AI That Delivers: Real World Automation Gains in Claims & Customer Operations
Where conversational AI and automation have actually reduced cost-to-serve.
Case studies showing measurable gains in claims and customer operations.
How to scale AI safely with governance, transparency, and human oversight, what has changed in workflows, data and proof points from real deployments.
MODERATOR: Cherie Landman, Head of Sales, EMEA, Boost AI
Agentic AI: The key enabler of insurance business model transformation
- Why Agentic AI is unlike any other form of digital technology
- How can insurers apply it to create new levels of growth and value
- Global best (and worst) practices
Beyond the Buzz: Profits, Pitfalls & the Next Frontier – Agentic AI
As insurers face mounting operational and demographic pressures, we explore whether agentic AI can move beyond hype to become the industry’s next true transformation layer.
Opening remarks
Opening remarks:
How to build your document intelligence capability in insurance
As insurers face growing pressure to process unstructured data faster and more accurately, document intelligence is becoming a critical capability across underwriting, claims, compliance and servicing workflows. We will go through
- Common implementation pitfalls: from poor data quality to disconnected workflows and low user adoption
- Exploring what is Agentic Document Extraction
- Where AI driven document processing is delivering measurable impact today across claims, underwriting and customer operation
Lunch and networking
Empowering small and mid‑size sponsors by adopting practical AI tools
- A pragmatic shortlist of AI use-cases where SMEs can realistically deploy now
- Vendor-evaluation criteria that filter for inspection-ready tools
- A budget-conscious framework for rolling out AI without acquiring governance debt
EXCLUSIVE FIRESIDE CHAT: Navigating FDA policy & politics in drug development under the Trump Administration
- Understanding how political priorities and leadership changes shape FDA expectations
- Balancing accelerated approvals and innovation with growing demands for robust evidence
- Navigating uncertainty around incentives, vouchers, and evolving policy frameworks
- Building flexible development strategies that can adapt to regulatory and political shifts
Moderator: Tia Williamson, Associate Director Development Operations Global Monitoring, Incyte